MedAvail Holdings Inc [MDVL] moved up 26.44: Why It’s Important


MedAvail Holdings Inc [NASDAQ: MDVL] price surged by 26.44 percent to reach at $0.46. The company report on April 28, 2022 that MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the first quarter of 2022 on Thursday, May 12, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investor Relations” section of MedAvail’s website at: The webcast will be archived and available for replay after the event.

A sum of 13013639 shares traded at recent session while its average daily volume was at 9.30M shares. MedAvail Holdings Inc shares reached a high of $2.31 and dropped to a low of $1.65 until finishing in the latest session at $2.20.

The one-year MDVL stock forecast points to a potential upside of 56.0. The average equity rating for MDVL stock is currently 2.00, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on MedAvail Holdings Inc [MDVL]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDVL shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDVL stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for MedAvail Holdings Inc is set at 0.49, with the Price to Sales ratio for MDVL stock in the period of the last 12 months amounting to 6.82. The Price to Book ratio for the last quarter was 2.32, with the Price to Cash per share for the same quarter was set at 0.52.

MDVL Stock Performance Analysis:

MedAvail Holdings Inc [MDVL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.92. With this latest performance, MDVL shares gained by 56.03% in over the last four-week period, additionally sinking by -17.60% over the last 6 months – not to mention a drop of -82.43% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDVL stock in for the last two-week period is set at 56.14, with the RSI for the last a single of trading hit 57.12, and the three-weeks RSI is set at 55.90 for MedAvail Holdings Inc [MDVL]. The present Moving Average for the last 50 days of trading for this stock 1.4700, while it was recorded at 1.8700 for the last single week of trading, and 2.4300 for the last 200 days.

Insight into MedAvail Holdings Inc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and MedAvail Holdings Inc [MDVL] shares currently have an operating margin of -196.62 and a Gross Margin at -4.91. MedAvail Holdings Inc’s Net Margin is presently recorded at -198.00.

Return on Equity for this stock declined to -109.35, with Return on Assets sitting at -81.54.

MedAvail Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.20 and a Current Ratio set at 4.60.

MedAvail Holdings Inc [MDVL] Insider Position Details

There are presently around $45 million, or 39.90% of MDVL stock, in the hands of institutional investors. The top three institutional holders of MDVL stocks are: REDMILE GROUP, LLC with ownership of 11,075,105, which is approximately -5.541% of the company’s market cap and around 16.20% of the total institutional ownership; ABG-WTT GLOBAL LIFE SCIENCE CAPITAL PARTNERS GP LTD, holding 3,885,951 shares of the stock with an approximate value of $6.76 million in MDVL stocks shares; and ALLY BRIDGE GROUP (NY) LLC, currently with $5.08 million in MDVL stock with ownership of nearly 0% of the company’s market capitalization.

23 institutional holders increased their position in MedAvail Holdings Inc [NASDAQ:MDVL] by around 729,657 shares. Additionally, 20 investors decreased positions by around 1,580,039 shares, while 16 investors held positions by with 23,729,981 shares. The mentioned changes placed institutional holdings at 26,039,677 shares, according to the latest SEC report filing. MDVL stock had 10 new institutional investments in for a total of 363,390 shares, while 6 institutional investors sold positions of 310,449 shares during the same period.